UPDATE: Credit Suisse Upgrades Corvus Pharmaceuticals (CRVS) to Neutral
Tweet Send to a Friend
(Updated - August 24, 2017 6:26 AM EDT)
(updated to add analyst comment)Credit Suisse upgraded Corvus Pharmaceuticals (NASDAQ: CRVS) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updated to add analyst comment)Credit Suisse upgraded Corvus Pharmaceuticals (NASDAQ: CRVS) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
